ArticleScience translational medicine2026

Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models.

Nalini R Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.